Delivery Order SPE2DB22D2007-SPE2DB24FJ3QY

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Concerta ER 27 mg tablets. The contract, valued at $3,647.44, is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Concerta ER 54 mg tablets. The $12,691.60 firm fixed-price delivery order has an ultimate completion date of January 9, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.72 firm-fixed-price delivery order is for the supply of Concerta ER 27 mg tablets. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. The fixed-price delivery order, valued at $5,371.80, has a completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) for the delivery of 4,564,997,894 units of Concerta ER 27 mg tablets. The contract, valued at $3,726.01, is a firm fixed-price delivery order with a completion date of June 26, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,070.77, is a delivery order for the supply of Concerta ER 18 mg tablets. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Concerta ER 27 mg tablets. The contract, valued at $6,832.56, is a firm-fixed price delivery order with a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
The federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Concerta ER 27 mg tablets to the Defense Logistics Agency (DLA). The $1,801.16 firm fixed-price delivery order contract has a completion date of February 11, 2025. This contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Concerta ER 27 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $3,695.34 and an ultimate completion date of May 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,606.20 firm fixed-price delivery order is for the supply of Concerta ER 18 mg tablets. The contract has an ultimate completion date of July 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3QY
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of Concerta ER 27 mg tablets. The contract, valued at $10,384.68, is a Firm Fixed Price Delivery Order with a completion date of June 26, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts and support the medical needs of the Department of Defense, Veterans Affairs, and other federal agencies.

Generated 9/24/24, 9:36 AM